Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV
収録刊行物
-
- Vaccine
-
Vaccine 27 1848-1857, 2009